다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Eyegate Pharmaceuticals Inc (EYEGW)
Eyegate Pharmaceuticals Inc (EYEGW) 뉴스

EYEGW

Eyegate Pharmaceuticals (EYEGW)

Eyegate Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EYEGW

1

일자	시간	출처	헤드라인	심볼	기업
2016/09/21	21:30	GlobeNewswire Inc.	EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/09/13	21:30	GlobeNewswire Inc.	EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/09/12	21:30	GlobeNewswire Inc.	EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/09/06	21:30	GlobeNewswire Inc.	EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/08/11	05:50	GlobeNewswire Inc.	EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/08/01	21:30	GlobeNewswire Inc.	EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammat...	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/07/01	02:00	GlobeNewswire Inc.	EyeGate Announces Completion of $3.77 Million Registered Direct Offering	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/06/27	21:00	GlobeNewswire Inc.	EyeGate Announces $3.77 Million Registered Direct Offering	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/06/01	21:30	GlobeNewswire Inc.	EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation an...	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/05/25	07:00	GlobeNewswire Inc.	EyeGate Pharma Announces At The Market Issuance Program	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/05/14	06:25	GlobeNewswire Inc.	Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/05/06	21:30	GlobeNewswire Inc.	EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and Development	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/04/29	00:46	GlobeNewswire Inc.	EyeGate Pharma to Present Four Posters at ARVO 2016 Annual Meeting Supporting Development of CMHA-S	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/04/28	05:05	GlobeNewswire Inc.	EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial Officer	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/03/30	05:45	GlobeNewswire Inc.	EyeGate Reports Full-year 2015 Financial Results and Provides Business Update	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/03/10	09:46	GlobeNewswire Inc.	EyeGate Pharma Acquires Jade Therapeutics	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/03/10	09:46	GlobeNewswire Inc.	EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/01/19	22:30	GlobeNewswire Inc.	EyeGate Pharma Enrolls First Patient in Confirmatory Phase 3 Clinical Trial EGP-437-006 for Non-Infectious Anterior Uveitis	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2016/01/14	23:49	GlobeNewswire Inc.	Eyegate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2015/11/12	22:30	GlobeNewswire Inc.	EyeGate Reports Third Quarter 2015 Financial Results and Provides Business Update	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2015/11/05	22:45	GlobeNewswire Inc.	EyeGate Announces Interim Data From Phase 1b / 2a Clinical Trial of Iontophoretic EGP-437 Ophthalmic Solution in Macular Edem...	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc
2015/10/15	21:30	GlobeNewswire Inc.	EyeGate Pharma Receives USPTO Notice of Allowance for Next Generation of Proprietary Iontophoretic Delivery System	NASDAQ:EYEGW	Eyegate Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:EYEGW

1

American Express

Health Care Select Sector

Financial Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관